Diplomat's clinical technology manager honored as finalist in 2014 Next-Generation Pharmacist awards

NewsGuard 100/100 Score

Diplomat, the nation's largest independent specialty pharmacy, is proud to announce that clinical technology manager Mike Crowe, PharmD, MBA, CSP, FMPA, was honored as a finalist in the 2014 Next-Generation™ Pharmacist awards. Crowe was selected as a finalist in two categories: rising star, which recognizes pharmacists defining the future standard of pharmacy practice, and specialty pharmacist, which recognizes pharmacists who excel in providing specialty pharmacy services and demonstrate innovation in specialty services.

The annual Next-Generation Pharmacist Awards, sponsored through a partnership of Parata Systems and Pharmacy Times, recognize outstanding professionals in 10 categories: civic leader, entrepreneur, future pharmacist, lifetime leadership, military pharmacist, patient care provider, rising star, specialty pharmacist, technician and technology innovator. This year, more than 500 individuals were nominated, with three finalists selected for each category.

"The judges had a strong, diverse group of pharmacists to choose from," said Ashley Hennessy Talamo, publisher at Pharmacy Times. "Every finalist represents the best and brightest of each category, and they are all making a difference in their fields."

As clinical technology manager at Diplomat, Crowe works closely with clinical services and business stakeholders determining the data to be collected as well as the collection methods. Crowe is also responsible for determining how the data can be utilized to demonstrate positive outcomes within the specialty pharmacy arena.

An active member in the pharmacy community, Crowe serves as the vice speaker of the Michigan Pharmacists Association and is also an officer on its executive board. Crowe is also chairman, past president and founder of the Genesee County Pharmacists Association.

Source:

Diplomat

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy